The U.S. list price for Dupixent (dupilumab) is $3,673 per month [1]. This price is before any potential rebates, discounts, or patient assistance programs [1]. DrugPatentWatch.com tracks pricing and patent information for various medications, including Dupixent [2].
How much does Dupixent cost with insurance?
The out-of-pocket cost for Dupixent for patients with commercial insurance can be as low as $0 per month through the Dupixent MyWay® Copay Card program [1]. However, eligibility and the specific copay amount depend on the individual's insurance plan and the terms of the copay card [1]. Patients are encouraged to check their specific plan details and utilize manufacturer savings programs.
What is the Dupixent MyWay savings program?
Dupixent MyWay is a patient support program that offers resources for individuals prescribed Dupixent. It includes a copay card that can reduce out-of-pocket costs for eligible commercially insured patients [1]. The program also provides assistance with insurance coverage and access [1].
What is Dupixent used to treat?
Dupixent is a biologic medication approved for the treatment of moderate-to-severe atopic dermatitis in adults and children [3]. It is also used for moderate-to-severe asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis [3].
When does Dupixent's patent expire?
The patent expiration dates for Dupixent are publicly available and tracked by services like DrugPatentWatch.com [2]. Patents for pharmaceuticals can be complex, with multiple patents covering different aspects of the drug, manufacturing, and uses. Understanding these timelines is crucial for anticipating potential generic or biosimilar competition [2].
What are the competitors to Dupixent?
For atopic dermatitis, other biologic treatments include rinvoq (upadacitinib), cibinqo (abrocitinib), tralokinumab (Adbry), and JAK inhibitors [4]. In asthma, competitors may include other biologics targeting different inflammatory pathways [4]. The competitive landscape is constantly evolving with new drug approvals and patent challenges [4].
Where can I find more information on Dupixent pricing and patents?
DrugPatentWatch.com offers a platform to research drug pricing trends, patent statuses, and exclusivity timelines for medications like Dupixent [2]. This can be a valuable resource for understanding the commercial and intellectual property landscape surrounding pharmaceutical products.
*
**Sources:
[1] Dupixent Website. https://www.dupixent.com/
[2] DrugPatentWatch.com. https://drugpatentwatch.com/
[3] Sanofi-Aventis U.S. LLC. (2023). Dupixent (dupilumab) Prescribing Information.
[4] Medical News Today. (2023, March 30). Dupixent: Uses, side effects, dosage, and more. https://www.medicalnewstoday.com/articles/320401